P991: ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) POTENTIATES APOPTOSIS IN MYELOBLASTS FROM PATIENTS (PTS) WITH MYELOFIBROSIS (MF)

Tracy Clevenger, Jean Cheung, Fanny Krantz, Michael Gulrajani, Cynthia Nguyen, Miranda Luarca, Cecile Krejsa, Wayne P. Rothbaum, Todd Covey

Open source

DOI: 10.1097/01.hs9.0000970868.28141.7f
Published: 2023-08
Container: HemaSphere
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1097/01.hs9.0000970868.28141.7f,
  title = {P991: ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) POTENTIATES APOPTOSIS IN MYELOBLASTS FROM PATIENTS (PTS) WITH MYELOFIBROSIS (MF)},
  author = {Tracy Clevenger and Jean Cheung and Fanny Krantz and Michael Gulrajani and Cynthia Nguyen and Miranda Luarca and Cecile Krejsa and Wayne P. Rothbaum and Todd Covey},
  year = {2023},
  journal = {HemaSphere},
  doi = {10.1097/01.hs9.0000970868.28141.7f},
  url = {https://doi.org/10.1097/01.hs9.0000970868.28141.7f}
}

RIS

TY  - JOUR
TI  - P991: ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) POTENTIATES APOPTOSIS IN MYELOBLASTS FROM PATIENTS (PTS) WITH MYELOFIBROSIS (MF)
AU  - Tracy Clevenger
AU  - Jean Cheung
AU  - Fanny Krantz
AU  - Michael Gulrajani
AU  - Cynthia Nguyen
AU  - Miranda Luarca
AU  - Cecile Krejsa
AU  - Wayne P. Rothbaum
AU  - Todd Covey
PY  - 2023
JO  - HemaSphere
DO  - 10.1097/01.hs9.0000970868.28141.7f
UR  - https://doi.org/10.1097/01.hs9.0000970868.28141.7f
ER  -

APA

Clevenger, T., Cheung, J., Krantz, F., Gulrajani, M., Nguyen, C., Luarca, M., Krejsa, C., Rothbaum, W. P., & Covey, T. (2023). P991: ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) POTENTIATES APOPTOSIS IN MYELOBLASTS FROM PATIENTS (PTS) WITH MYELOFIBROSIS (MF). HemaSphere. https://doi.org/10.1097/01.hs9.0000970868.28141.7f

Source records

crossref · retrieved 2026-09-27T10:50:02.914Z